Business & Economics

1. Drug Development 100%
2. Financing 82%
3. Private Firms 79%
4. Funding 78%
5. Innovation 69%
6. R and D 68%
7. Biopharmaceutical Industry 65%
8. Financial Institutions 63%
9. Food and Drug Administration 56%
10. Investors 55%
11. Orphans 55%
12. Cash 53%
13. Short-termism 52%
14. Windfall 50%
15. Mandatory Disclosure 50%
16. Going Public 49%
17. Peer Effects 49%
18. Cash Flow 49%
19. Disclosure Requirements 47%
20. Intermediaries 46%
21. Financial Intermediation 44%
22. Fault 43%
23. Injection 43%
24. Debt Crisis 42%
25. Propensity 41%
26. Reallocation 40%
27. Transparency 40%
28. Drugs 39%
29. Healthcare 38%
30. Farming 37%
31. Reward 37%
32. Hedge 36%
33. Debt 36%
34. Bankruptcy 35%
35. Company Value 34%
36. Farm 32%
37. Farmers 30%
38. Liquidity 30%
39. Labor Contracts 28%
40. Managers 28%
41. R&D Investment 26%
42. Market Frictions 24%
43. Renegotiation 22%
44. Friction 22%
45. Productivity 22%
46. Sharpe Ratio 21%